Article Text

Download PDFPDF
Hydroxychloroquine-induced hypoglycaemia in non-diabetic renal patient on peritoneal dialysis
  1. Ahmed El-Solia1,
  2. Khalid Al-Otaibi2,
  3. Abdullah K AI-Hwiesh3
  1. 1Renal Department, Southend University Hospital NHS Foundation Trust, Westcliff-on-Sea, Essex, UK
  2. 2Urology Department, Abdulrahman Bin Faisal University, King Fahd Hospital of the University, Dammam, Saudi Arabia
  3. 3Internal Medicine Department, Nephrology Division, Imam Abdulrahman Bin Faisal University, King Fahd Hospital of the University, Dammam, Saudi Arabia
  1. Correspondence to Dr Ahmed El-Solia, dr_ahmed_solia{at}


Hydroxychloroquine (HCQ) is a commonly used drug for the treatment of systemic lupus erythematosus (SLE). Renal involvement is common in SLE. We present a 25-year-old woman with lupus nephritis on peritoneal dialysis whose lupus was quite silent for almost three years, and secondary to HCQ she developed severe hypoglycaemic episodes, which were completely resolved after stopping HCQ.

  • renal system
  • unwanted effects/adverse reactions
  • dialysis
  • systemic lupus erythematosus
  • drugs: musculoskeletal and joint diseases
View Full Text

Statistics from


  • Contributors AE-S has reviewed the literature and written the first draft. KA-O and AKA-H have participated in the discussion section and revised the draft for the final version.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.